Danaher EBIT 2010-2025 | DHR
Danaher annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
- Danaher EBIT for the quarter ending March 31, 2025 was $1.274B, a 2.9% decline year-over-year.
- Danaher EBIT for the twelve months ending March 31, 2025 was $4.825B, a 3.44% decline year-over-year.
- Danaher 2024 annual EBIT was $4.863B, a 6.52% decline from 2023.
- Danaher 2023 annual EBIT was $5.202B, a 30.97% decline from 2022.
- Danaher 2022 annual EBIT was $7.536B, a 18.17% increase from 2021.
| Danaher Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $4,863 |
| 2023 | $5,202 |
| 2022 | $7,536 |
| 2021 | $6,377 |
| 2020 | $4,231 |
| 2019 | $3,269 |
| 2018 | $3,055 |
| 2017 | $2,572 |
| 2016 | $2,735 |
| 2015 | $2,162 |
| 2014 | $2,045 |
| 2013 | $3,121 |
| 2012 | $3,165 |
| 2011 | $2,617 |
| 2010 | $2,050 |
| 2009 | $1,440 |
| Danaher Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,274 |
| 2024-12-31 | $1,425 |
| 2024-09-30 | $958 |
| 2024-06-30 | $1,168 |
| 2024-03-31 | $1,312 |
| 2023-12-31 | $1,337 |
| 2023-09-30 | $1,185 |
| 2023-06-30 | $1,163 |
| 2023-03-31 | $1,517 |
| 2022-12-31 | $1,144 |
| 2022-09-30 | $2,015 |
| 2022-06-30 | $2,205 |
| 2022-03-31 | $2,172 |
| 2021-12-31 | $1,066 |
| 2021-09-30 | $1,309 |
| 2021-06-30 | $2,005 |
| 2021-03-31 | $1,997 |
| 2020-12-31 | $1,601 |
| 2020-09-30 | $1,088 |
| 2020-06-30 | $844 |
| 2020-03-31 | $698 |
| 2019-12-31 | $961 |
| 2019-09-30 | $776 |
| 2019-06-30 | $812 |
| 2019-03-31 | $720 |
| 2018-12-31 | $614 |
| 2018-09-30 | $831 |
| 2018-06-30 | $868 |
| 2018-03-31 | $743 |
| 2017-12-31 | $519 |
| 2017-09-30 | $759 |
| 2017-06-30 | $677 |
| 2017-03-31 | $617 |
| 2016-12-31 | $713 |
| 2016-09-30 | $699 |
| 2016-06-30 | $710 |
| 2016-03-31 | $613 |
| 2015-12-31 | $-7 |
| 2015-09-30 | $480 |
| 2015-06-30 | $934 |
| 2015-03-31 | $755 |
| 2014-12-31 | $887 |
| 2014-09-30 | $866 |
| 2014-06-30 | $889 |
| 2014-03-31 | $789 |
| 2013-12-31 | $888 |
| 2013-09-30 | $812 |
| 2013-06-30 | $844 |
| 2013-03-31 | $731 |
| 2012-12-31 | $863 |
| 2012-09-30 | $756 |
| 2012-06-30 | $811 |
| 2012-03-31 | $735 |
| 2011-12-31 | $779 |
| 2011-09-30 | $643 |
| 2011-06-30 | $610 |
| 2011-03-31 | $585 |
| 2010-12-31 | $557 |
| 2010-09-30 | $553 |
| 2010-06-30 | $518 |
| 2010-03-31 | $422 |
| 2009-12-31 | $291 |
| 2009-09-30 | $465 |
| 2009-06-30 | $344 |
| 2009-03-31 | $340 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $140.550B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.61 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.62 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| OncoCyte (IMDX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |